These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22318326)

  • 1. Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.
    Lorentini S; Amichetti M; Spiazzi L; Tonoli S; Magrini SM; Fellin F; Schwarz M
    Strahlenther Onkol; 2012 Mar; 188(3):216-25. PubMed ID: 22318326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
    Krayenbuehl J; Riesterer O; Graydon S; Dimmerling P; Kloeck S; Ciernik IF
    J Appl Clin Med Phys; 2013 Jul; 14(4):4130. PubMed ID: 23835378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
    Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.
    Sterzing F; Sroka-Perez G; Schubert K; Münter MW; Thieke C; Huber P; Debus J; Herfarth KK
    Radiother Oncol; 2008 Feb; 86(2):251-7. PubMed ID: 18207597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
    Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H
    Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture.
    Su Z; Indelicato DJ; Mailhot RB; Bradley JA
    J Appl Clin Med Phys; 2020 Jun; 21(6):100-107. PubMed ID: 32268008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of volumetric-modulated arc therapy for malignant pleural mesothelioma.
    Runxiao L; Yankun C; Lan W
    J Appl Clin Med Phys; 2016 Mar; 17(2):139-144. PubMed ID: 27074478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
    Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
    Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.
    Javedan K; Stevens CW; Forster KM
    J Appl Clin Med Phys; 2008 Oct; 9(4):98-109. PubMed ID: 19020484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
    Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
    Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
    Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
    Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
    Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
    Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
    Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
    Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
    Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.